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Objectives This study sought to assess the relationship between central pressure profiles and cardiovascular events (CVEs)
in a large community-based sample.
Background Experimental and physiologic data mechanistically implicate wave reflections in the pathogenesis of left ventricular
failure and cardiovascular disease, but their association with these outcomes in the general population is unclear.
Methods Aortic pressure waveforms were derived from a generalized transfer function applied to the radial pressure
waveform recorded noninvasively from 5,960 participants in the Multiethnic Study of Atherosclerosis. The cen-
tral pressure waveform was separated into forward and reflected waves using a physiologic flow waveform. Re-
flection magnitude (RM  [Reflected/Forward wave amplitude]  100), augmentation index ([Second/First sys-
tolic peak]  100) and pulse pressure amplification ([Radial/aortic pulse pressure]  100) were assessed as
predictors of CVEs and congestive heart failure (CHF) during a median follow-up of 7.61 years.
Results After adjustment for established risk factors, aortic AIx independently predicted hard CVEs (hazard ratio [HR] per
10% increase: 1.08; 95% confidence interval [CI]: 1.01 to 1.14; p  0.016), whereas PPA independently pre-
dicted all CVEs (HR per 10% increase: 0.82; 95% CI: 0.70 to 0.96; p  0.012). RM was independently predictive
of all CVEs (HR per 10% increase: 1.34; 95% CI: 1.08 to 1.67; p  0.009) and hard CVEs (HR per 10% increase:
1.46; 95% CI: 1.12 to 1.90; p  0.006) and was strongly predictive of new-onset CHF (HR per 10% increase:
2.69; 95% CI: 1.79 to 4.04; p  0.0001), comparing favorably to other risk factors for CHF as per various mea-
sures of model performance, reclassification, and discrimination. In a fully adjusted model, compared to nonhy-
pertensive subjects with low RM, the HRs (95% CI) for hypertensive subjects with low RM, nonhypertensive sub-
jects with high RM, and hypertensive subjects with high RM were 1.81 (0.85 to 3.86), 2.16 (1.07 to 5.01), and
3.98 (1.96 to 8.05), respectively.
Conclusions Arterial wave reflections represent a novel strong risk factor for CHF in the general population. (J Am Coll Cardiol
2012;60:2170–7) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.07.054Several considerations support a mechanistic role for central
pressure profiles as causal determinants of cardiovascular
disease (1–3). The aortic pressure profile is determined by
the interactions between the left ventricle (LV) and the load
imposed by the arterial tree (4). Wave reflections arising in
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prominent late systolic load adversely affects LV structure
and function (5– 8).
Central pulse pressure and arterial wave reflections can be
assessed noninvasively with arterial tonometry. The aortic
augmentation index (AIx), which depends on the pressure
difference between the first and second systolic peaks (Fig. 1), has
been a widely used surrogate of wave reflections. However,
AIx is not only influenced by the magnitude of wave
reflections but also confounded by their timing, heart rate,
body height, and other factors (9,10). When central pressure
and flow waveforms are known, the aortic pressure wave can
be separated into its forward and reflected components
(wave separation analysis), allowing for the measurement of
reflection magnitude (RM), defined as the dimensionless
atio of the amplitudes of backward/forward waves. This
omputation does not depend on the calibration of the flow
aveform and can be approximated using pressure information
nly, assuming a triangular or a physiologic flow waveform
Fig. 1) (11,12).
An issue of great interest is whether central pressure
arameters are associated with incident cardiovascular
vents (CVEs) independently of brachial pressures. A recent
eta-analysis (3) suggested that central AIx independently
redicts CVEs. In contrast, more recent data from 2,232
ramingham Heart Study participants indicated that ca-
otid AIx or pulse pressure did not independently predict
ajor CVEs (13). This study did not perform wave sepa-
ation analysis and relayed on brachial arterial tonometry for
omputation of pulse pressure amplification, an approach
hat has been challenged by some investigators based on
natomic factors that may impede proper applanation
Figure 1 Radial Pressure Waveform
Radial pressure waveform averaged from a 30-s recording (top left) and correspondin
on identification of the first and second systolic peaks, augmentation index (AIx) c
computed from the ratio of peripheral (radial) pulse pressure (PPP)/central (aortic)
wave can be separated into its forward (Pf) and reflected (backward, Pb) waves an
(Pb/Pf). For consistency, we expressed all indices as percentages (ratios  100).tonometry of the brachial artery
(14). In another recent study
among 1,272 Taiwanese subjects,
reflected wave amplitude com-
puted with a triangular flow
waveform, but not carotid AIx,
predicted all-cause mortality as-
sessed from a National Death
Registry 15 years later (15).
Given the adverse impact of
wave reflections on the LV (5–7)
and the large public health bur-
den of heart failure and cardio-
vascular disease, further data re-
garding the association between
wave reflections and these out-
comes are needed. In this ancil-
lary study of data from the MESA (Multiethnic Study of
Atherosclerosis), a large community-based multiethnic co-
hort study that enrolled adults free of cardiovascular disease
(16), this study aimed to assess the relationship between
central pressure profiles and: 1) incident hard CVEs; and
2) incident congestive heart failure (CHF).
Methods
Study population. MESA enrolled 6,814 men and women
ages 45 to 84 years who identified themselves as white,
African American, Hispanic, or Chinese and who were free
of clinically apparent cardiovascular disease, from 6 U.S.
communities between 2000 and 2002 (16). The study was
Abbreviations
and Acronyms
AIx  augmentation Index
CHF  congestive heart
failure
CVE  cardiovascular
event(s)
LV  left ventricle
NRI  net reclassification
improvement
PPA  pulse pressure
amplification
rIDI  relative integrated
discrimination improvement
RM  reflection magnitude
c pressure waveform obtained with a generalized transfer function (top right). Based
computed based on the ratio of P2/P1. Pulse pressure amplification (PPA) is
pressure (CPP). Using a physiologic flow waveform (bottom left), the aortic
ction magnitude (RM) can be computed based on the ratio of the amplitudes ofg aorti
an be
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centers and participants gave informed consent.
Data collection. Standardized questionnaires were used to
obtain information about cardiovascular risk factors and
medication use. Resting blood pressure was measured in
triplicate using a Dinamap-Pro100 oscillometric sphygmo-
manometer (GE Medical Systems, Waukesha, Wisconsin).
The average of the last 2 measurements was used. Hyper-
tension was defined as systolic blood pressure 140 mm Hg,
diastolic blood pressure 90 mm Hg, and/or antihyperten-
ive medication use (17). Serum total cholesterol, high-
ensity lipoprotein (HDL) cholesterol, and glucose were
easured after a 12-h fast. Diabetes mellitus was defined as
asting glucose 126 mg/dl and/or hypoglycemic medica-
ion use (18).
emodynamic measurements. Radial arterial waveform
0-s recordings were obtained at baseline in the supine
osition using the HDI/PulseWave-CR2000 tonometry
evice (Hypertension Diagnostics, Eagan, Minnesota), dig-
tized at 200 Hz and exported for offline processing using
ustom-designed software written in Matlab (The Math-
orks, Natick, Massachusetts).
A generalized transfer function (19) was applied to the
adial pressure waveform to obtain a central pressure wave-
orm. Aortic-radial pulse pressure amplification (PPA) was
omputed as: (radial pulse pressure/aortic pulse pressure) 
100 (Fig. 1). This computation does not depend on cali-
bration of the radial pressure waveform.
The first and second systolic peaks were identified in the
aortic pressure waveform as previously described (20). AIx
was computed as (Second/First systolic peak)  100
(Fig. 1). A physiologic flow waveform (11) was used for
separation of the pressure wave into forward and reflected
waves (21). RM was calculated as shown in Equation 1
(Fig. 1).
backward wave amplitude
forward wave amplitude
 100
Further details about this analysis methods can be found in
the Online Appendix.
Event adjudication. In addition to undergoing 3 on-site
xaminations, participants were contacted by a telephone
nterviewer every 9 to 12 months to inquire about incident
VEs. Two physicians independently reviewed copies of
edical records and death certificates for hospitalizations
nd outpatient cardiovascular diagnoses, for blinded end-
oint classification using pre-specified criteria (22), as sum-
marized in the Online Appendix. The following endpoints
ere defined a priori for this study: 1) hard CVEs, defined as
composite prevalence of myocardial infarction, resusci-
ated cardiac arrest, cardiovascular disease–related death,
troke, or stroke-related death; 2) all CVEs, defined as a
omposite prevalence of any hard CVE, angina, other
therosclerosis-related death, or other cardiovascular dis-
ase–related death; and 3) CHF, which required clinical symptoms (e.g., dyspnea) or signs (e.g., edema), a physi-
ian’s diagnosis of CHF, and medical treatment for CHF,
n addition to: a) pulmonary edema/congestion by chest
adiography; and/or b) dilated ventricle or poor LV function
y echocardiography or ventriculography, or evidence of LV
iastolic dysfunction. Whereas the 2 former are composite
ndpoints commonly used in cardiovascular risk studies,
HF was defined as a specific endpoint a priori based on
revious experimental data.
tatistical analysis. A more detailed description of the
tatistical methods can be found in the Online Appendix.
he association between hemodynamic measures and time
o CVE or CHF was examined using the Kaplan-Meier
ethod and Cox regression. Model goodness-of-fit was
ssessed with the Akaike’s information criterion and Bayes-
an information criterion (23,24). Model discrimination was
ssessed with the Harrel’s c-index (which is analogous to the
rea under the receiver operator characteristic curve)
23,25). Calibration was assessed with the Hosmer-
emeshow test. Improvements in subject reclassification
as further assessed using the net reclassification improve-
ent (NRI) (23,25), which depends on the increased
robability that a new model will categorize case subjects as
igher risk and on the decreased probability that it will
ategorize control subjects as lower-risk, compared to a base
odel, as explained in more detail in the Online Appendix.
e computed 2 versions of the NRI: a category-based NRI
ased on usual categories for 10-year cardiovascular disease
isk (adapted at 5 years as 2.5%, 2.5 to 5%, 5 to 10%,
nd 10%). Because no established categories exist that
uide clinical decisions for CHF risk, we computed
ategory-free reclassification measures, which are indepen-
ent on arbitrarily defined risk thresholds (26). These
nclude the category-free NRI and the relative integrated
iscrimination improvement (rIDI), which expresses the
elative improvement in discrimination slopes (difference in
ean predicted probabilities between case and control
articipants) between the base model and new model
23,25–27). Various indices of model performance were
sed to: 1) assess the added predictive value of central
ressure indices; and 2) compare the predictive value of
ortic hemodynamic indices to that of well-established risk
actors, as previously described (23).
All tests were 2-sided with alpha  0.05. Analyses were
erformed using SPSS version 19.0 (SPSS Inc., Chicago,
llinois).
esults
f 6,336 participants who underwent radial tonometry,
,153 (97.1%) had technically adequate data. Central wave-
orms from 164 subjects had no discernible inflections (due
o merging of the first and second peaks) or 1 inflection,
mpeding adequate identification of the first and second
ystolic peaks. Twenty-nine participants had no follow-up
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Table 1 shows baseline characteristics of subjects included in
this study.
Cardiovascular events. During a median follow-up of 7.61
(interquartile range: 7.34 to 7.78) years, 407 subjects expe-
rienced a first CVE, 281 subjects experienced a first hard
CVE, and 117 experienced a first episode of CHF. Hazard
ratios (HRs) for incident CVE and CHF associated with a
10-point increase in AIx, RM, or PPA are shown in Table 2.
Table 2 also shows standardized HRs (those associated with
a 1-SD increase in the predictors). In adjusted analyses, AIx
was independently associated with hard CVEs (model 3,
Baseline Characteristicsof Study Participant (N  5,960)Table 1 B seline Characteristicsof Study Participants (N  5,960)
Age, yrs 62 (53–70)
Sex
Male 2,862 (48)
Female 3,096 (52)
Ethnicity
White 2,240 (37.6)
African American 1,620 (27.2)
Chinese American 728 (12.2)
Hispanic American 1,370 (23.0)
Body measurements
Height, cm 166 (159–174)
Weight, kg 77.1 (66.2–89.4)
BMI, kg/m2 27.5 (24.6–31.2)
Hemodynamic variables
Brachial SBP, mm Hg 124 (111–140)
Brachial DBP, mm Hg 72 (65–78.5)
Heart rate, bpm 63 (57–70)
Aortic augmentation index, % 145 (135–159)
RM, % 84 (81–87)
PPA, % 1.10 (1.05–1.17)
Laboratory analysis, mg/dl
Total cholesterol 192 (171–215)
LDL-cholesterol 116 (96–136)
HDL-cholesterol 48 (40–59)
Triglycerides 112 (78–162)
Estimated GFR, ml·min–1·1.73 m–2 80 (70–92)
Risk factors
Diabetes mellitus 755 (12.7)
Current smoking 2,151 (36.1)
Hypertension 2,667 (44.8)
Hypertension medication use 2,207 (37)
CVEs
Myocardial infarction 112 (1.9)
Heart failure 104 (1.7)
Stroke 100 (1.7)
All hard CVEs 148 (2.5)
All CVEs 258 (4.3)
Any hard CVE 241 (4.0)
Any CVE 356 (6.0)
Values are median (interquartile range) or n (%).
BMI body mass index; CVE  cardiovascular event(s); DBP  diastolic blood pressure; GFR 
glomerular filtration rate; IQR  interquartile range; RM  reflection magnitude; SBP  systolic
blood pressure.Table 2) (HR per 10% increase: 1.08; 95% confidenceinterval [CI]: 1.01 to 1.14; p  0.016). The category-free
NRI, rIDI and increase in c-index achieved by adding PPA
to the other variables in this model were 0.036, 0.002, and
0.004, respectively. PPA was independently associated with
all CVEs (model 3, Table 2) (HR per 10% increase: 0.82;
95% CI: 0.70 to 0.96; p  0.012). The category-free NRI,
rIDI, and increase in c-index achieved by adding PPA to the
other variables in this model were 0.10, 0.02, and 0.002,
respectively. PPA and AIx were not independently associ-
ated with incident CHF.
RM was independently associated with incident CVEs.
After adjustment for age, sex, ethnicity, systolic blood
pressure, diastolic blood pressure, antihypertensive medica-
tion use, height, weight, diabetes mellitus, total cholesterol,
HDL cholesterol, current smoking, heart rate, and glomer-
ular filtration rate, a 10% increase in RM was predictive of
a higher risk for CVEs (HR: 1.34; 95% CI: 1.08 to 1.67;
p  0.009) and hard CVEs (HR per 10% increase: 1.46; 95%
CI: 1.12 to 1.90; p  0.006). The category-free NRI, rIDI,
and increase in c-index for the prediction of all CVEs achieved
y adding RM to the other variables shown in model 3
Table 2) were 0.15, 0.05, and 0.002, respectively. The
ategory-free NRI, rIDI, and increase in c-index for the
rediction of hard CVEs when RM was added to the other
ariables shown in model 3 (Table 2) were 0.13, 0.08, and
.002, respectively.
RM was strongly predictive of incident CHF (HR per 10%
ncrease: 2.69; 95% CI: 1.79 to 4.04; p  0.0001; Table 2).
able 3 shows independent predictors of incident CHF in a
ully adjusted model, together with standardized HRs for each
erm, in order to allow for easier comparison between various
redictors. The full model is similar to the one used in Table 2,
ith the exceptions of height and weight, which were
eplaced by body mass index to more intuitively assess the
ndependent contribution of obesity to CHF risk prediction
n the model. Table 3 also shows improvements in model
erformance observed when individual predictors were
dded to a model containing all other variables except the
redictor in question. RM was associated with a standard-
zed HR of 1.61 (95% CI: 1.32 to 1.96), the largest Wald
tatistic and the greatest decreases in Akaike’s information
riterion and Bayesian information criterion (indicating
mprovement in model fit) and the greatest increases in IDI
nd rIDI. With the exception of age, a nonmodifiable risk
actor, RM was associated with the greatest NRI. Of note,
hese improvements in model performance were also supe-
ior to changes induced by adding systolic blood pressure
nd diastolic blood pressure together.
The addition of RM to a model containing all other
ariables shown in Table 3 resulted in a category-free NRI
of 0.38 and a rIDI of 0.48, indicating a 48% relative increase
in the discrimination slope achieved by all variables in the
base model. The addition of RM to the model resulted in a
category-based NRI of 0.17. A category-dependent reclas-
sification table can be found in Online Table 1. The full
N
0
t
(
N
nd syst
2174 Chirinos et al. JACC Vol. 60, No. 21, 2012
Wave Reflections and Heart Failure Risk November 20/27, 2012:2170–7model containing RM demonstrated adequate calibration
(Hosmer-Lemeshow chi square: 8.50; p  0.49).
Finally, in order to more directly compare the value of
brachial pulse pressure versus RM as predictors of CHF,
RM or brachial pulse was separately added to a base model
that included age, sex, body mass index, diabetes mellitus,
ethnicity, antihypertensive medication use, total cholesterol,
HDL cholesterol, current smoking, heart rate, and esti-
mated glomerular filtration rate. When RM was added to
this base model, the standardized HR for RM was 1.54
(95% CI: 1.26 to 1.88; p  0.0001), with an achieved
RI, rIDI, and increase in c-index of 0.32, 0.42, and
.011, respectively. When pulse pressure was added to
his base model, the standardized HR for RM was 1.42
95% CI: 1.18 to 1.70; p  0.0001), with an achieved
RI, rIDI and increase in c-index of 0.27, 0.20, and
0.011, respectively.
Results of Cox Proportional Hazards Models Examining the RelatioH modynamic Variables at Baseline and the Risk for CVEs, IncludiTable 2 Results of Cox Proportional Hazards Models ExaminingHemodynamic Variables at Baseline and the Risk for C
Hemodynamic Variable
Crude (N  5,960)
HR (95% CI) per
10% Increase
Standardized HR
(95% CI) p Value
HR (95
10% I
RM‡
All CVEs 1.48 (1.2–1.81) 1.21 (1.09–1.34) 0.0001 1.38 (1
All hard CVEs 1.66 (1.29–2.13) 1.28 (1.13–1.45) 0.0001 1.52 (1
Heart failure 2.61 (1.75–3.88) 1.60 (1.32–1.94) 0.0001 2.75 (1
Augmentation index§
All CVEs 1.05 (1.004–1.09) 1.11 (1.01–1.21) 0.031 1.03 (0
All hard CVEs 1.07 (1.02–1.13) 1.17 (1.05–1.30) 0.005 1.05 (0
Heart failure 1.06 (0.98–1.14) 1.14 (0.97–1.34) 0.14 1.03 (0
PPA
All CVEs 0.92 (0.82–1.02) 0.92 (0.83–1.02) 0.09 0.98 (0
All hard CVEs 0.92 (0.81–1.04) 0.92 (0.81–1.04) 0.19 1.02 (0
Heart failure 0.91 (0.75–1.11) 0.92 (0.76–1.11) 0.37 1.05 (0
*Hazard ratios correspond to a 10% increase (or a 10-point increase in the indices shown betwee
standard deviation of the examined variable. †Adjusted model 1 includes age, gender, total choles
2 further adjusts for ethnicity, body height, body weight, antihypertensive medication use, heart ra
‡RM (Reflected wave amplitude/Forward wave amplitude) 100. §Augmentation index (Seco
CI  confidence interval; HR  hazard ratio; other abbreviations as in Table 1.
Predictors of Incident Heart Failure in Multivariate Analysis (N  5Table 3 Predictors of Incident Heart Failure in Multivariate Ana
Predictor
Full Model With Adjusted HRs
(c-Index: 0.802; AIC: 1893; BIC: 1943)
Standardized HR
(95% CI) Wald Statistic p Va
Age (10 yrs) 1.62 (1.26–2.08) 14.44 0.00
Male 1.74 (1.38–2.21) 21.37 0.00
BMI (10 kg/m2) 1.26 (1.03–1.55) 4.83 0.02
Diabetes mellitus 1.24 (1.07–1.44) 8.37 0.00
SBP (10 mm Hg) 1.69 (1.33–2.13) 18.97 0.00
DBP (10 mm Hg) 0.67 (0.52–0.86) 9.71 0.00
Reflection magnitude (10%) 1.61 (1.32–1.96) 22.03 0.00
SBP and DBP together — — —
*Only significant predictors of CHF are shown. However, all models are also adjusted for ethnicit
estimated GFR. All HRs are standardized. †Larger decreases (changes with negative sign) indicat
reclassification or discrimination. §p  0.05. Improvements in model performance when both SBAIC Akaike information criterion; BIC Bayesian information criterion; IDI integrated discriminatio
improvement (category free); other abbreviations as in Tables 1 and 2.Figure 2A shows cumulative hazard curves for incident
CHF among subjects, stratified by RM tertiles. There was a
progressive increase in CHF risk with increasing RM tertile
(p  0.0001). For further comparison of the risk for CHF
associated with hypertension versus increased RM, the
population was stratified according to the presence (preva-
lence: 45%) or absence of hypertension. The population was
also stratified into those above or below the 55th RM
percentile to obtain a prevalence of ”high” RM identical to
the prevalence of hypertension (45%), allowing for a more
direct comparison of the contribution of each factor to CHF
risk in the population. Figures 2B and 2C show adjusted
cumulative hazard functions for each substratum according
to the presence or absence of hypertension and high RM. As
shown, nonhypertensive subjects with low RM were at
lowest risk, hypertensive subjects with high RM were at
highest risk, and hypertensive subjects with low RM and
Betweenart Failure, During Follow-Up*Relationship Between
Including Heart Failure, During Follow-Up*
ted Model 1† (n  5,937) Adjusted Model 2† (n  5,934)
per
e
Standardized HR
(95% CI) p Value
HR (95% CI) per
10% Increase
Standardized HR
(95% CI) p Value
71) 1.17 (1.05–1.30) 0.004 1.34 (1.08–1.67) 1.15 (1.04–1.28) 0.009
98) 1.23 (1.08–1.40) 0.002 1.46 (1.12–1.90) 1.20 (1.06–1.37) 0.006
12) 1.64 (1.35–2.00) 0.0001 2.69 (1.79–4.04) 1.62 (1.33–1.98) 0.0001
08) 1.07 (0.98–1.19) 0.19 1.05 (1.00–1.11) 1.12 (1.00–1.25) 0.052
11) 1.12 (0.99–1.26) 0.058 1.08 (1.01–1.14) 1.17 (1.03–1.33) 0.016
12) 1.07 (0.89–1.28) 0.50 1.08 (0.99–1.17) 1.17 (0.97–1.42) 0.11
10) 0.99 (0.89–1.10) 0.78 0.82 (0.70–0.96) 0.82 (0.71–0.96) 0.012
16) 1.02 (0.90–1.15) 0.81 0.87 (0.72–1.05) 0.87 (0.73–1.05) 0.15
28) 1.04 (0.86–1.27) 0.67 0.82 (0.61–1.10) 0.82 (0.62–1.09) 0.18
theses in the formulas above). Standardized HRs represent the risk increase for an increase in 1
DL-cholesterol, smoking, systolic and diastolic blood pressure, diabetes mellitus. Adjusted model
estimated glomerular filtration rate. Complete covariate data was available from 5,934 subjects.
olic peak/First systolic peak) 100. PPA (Radial pulse pressure/Aortic pulse pressure) 100.
)*(N  5,934)*
Effects of Adding Individual Predictors to a
Model Containing All Other Variables
Change in
BIC†
Change in
AIC†
Change in
c-Index‡ NRI‡ IDI‡ rIDI‡
–10.10 –12.87 0.020 0.47§ 0.010§ 0.22§
–17.09 –19.85 0.015 0.34§ 0.017§ 0.44§
0.15 –2.62 0.007 0.32§ 0.002 0.050
–3.09 –5.86 0.010 0.019 0.003 0.061
–13.10 –15.86 0.013 0.31§ 0.011§ 0.25§
–4.94 –7.70 0.006 0.15§ 0.007§ 0.14§
–17.79 –20.55 0.011 0.38§ 0.018§ 0.48§
–8.46 –13.98 0.013 0.28§ 0.011§ 0.25§
ypertensive medication use, total cholesterol, HDL-cholesterol, current smoking, heart rate, and
er improvement in model fit. ‡Larger increases indicate a larger improvement in performance in
DBP are added to a model containing all other variables contained in the full model.nshipg Het e
VEs,
Adjus
% CI)
ncreas
.11–1.
.17–1.
.83–4.
.99–1.
.99–1.
.95–1.
.88–1.
.89–1.
.86–1.
n paren
terol, H
te, and,934lysis
lue
01
01
8
4
01
2
01
y, antih
e a larg
P andn improvement; rIDI relative integrated discrimination improvement; NRI net reclassification
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ate risk for incident CHF.
Discussion
This study identifies an important novel independent risk
factor for new-onset CHF among adults in the general
population who are free of clinically apparent cardiovascular
disease. In this large multiethnic sample, the magnitude of
arterial wave reflections assessed noninvasively via radial
arterial tonometry was a strong predictor of incident CHF.
RM was also a significant predictor of incident CVE, but its
association with this composite endpoint was not as strong
as its association with CHF.
Physiologic principles (28) and experimental studies
(4–6) directly implicate wave reflections in the pathogenesis
of LV failure, but this is the first study to assess their
association with the risk for incident CHF in humans. The
pressure (and flow) wave generated by the LV (forward
wave) is transmitted by conduit vessels and partially re-
flected at sites of impedance mismatch, such as points of
branching or change in wall diameter or material properties
along the arterial tree as well as at the junction of small
conduit arteries with high-resistance arterioles, in which
mean pressure falls precipitously (4,29). Multiple small
reflections travel back to the proximal aorta and merge into
a “net” reflected wave. It has been long known that arterial
wave reflections profoundly affect LV afterload (4,28–30).
Due to the finite wave transit time from the heart to
reflection sites and back to the proximal aorta, in adults
beyond youth, wave reflections typically increase LV after-
load in mid to late systole (4,29). For any given level of
systolic blood pressure, a pattern characterized by prominent
late-systolic load has been unequivocally demonstrated to
exert deleterious effects on LV structure and function in
animal models (4–6), observations that have been sup-
ported by human studies (7,8). Consistent with these
mechanistic data, this study indicates that wave reflections
are important predictors of CHF risk. Wave reflections are
thought to be generated predominantly near muscular
(medium-sized) and smaller arterial segments and are highly
modifiable. Vasoactive drugs such as organic nitrates pro-
foundly decrease wave reflections despite small effects on
brachial pressures (31). Therefore, these findings not only
have implications for CHF risk assessment but also may
identify a potential novel therapeutic target for CHF pre-
vention. However, this study does not prove that this is a
suitable therapeutic strategy, and this issue will need to be
addressed in appropriately designed clinical trials.
Some previous studies assessing the association between
central pressures and incident CVE included populations
with manifest cardiovascular or renal disease (3). Studies in
the general population (e.g., the Strong Heart Study [32] or
Framingham Heart Study [13]) have been restricted to a
single ethnic group and examined composite CVE end-Figure 2 Reflection Magnitude as a
Predictor of Incident Heart Failure
(A) Cumulative hazard for heart failure among subjects stratified according to
tertiles of reflection magnitude (RM). (B) Hazard function for incident of heart
failure in subjects stratified according to the presence or absence of hyperten-
sion (prevalence: 45%) or reflection magnitude above (“high” RM) or below
(“low” RM) the 55th percentile (prevalence of “high” RM: 45%), adjusted for
other significant heart failure predictors shown in Table 3. (C) Analogous haz-
ard functions after further adjustment for ethnicity, antihypertensive medication
use, total-cholesterol, HDL-cholesterol, current smoking, glomerular filtration
rate, and heart rate.points. Furthermore, previous studies assessed central pulse
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separation analysis. Several studies suggest that AIx is
predictive of composite CVE endpoints among subjects
with established cardiac or renal disease (3). However,
central AIx and pulse pressure did not predict CVE inde-
pendently of brachial pressures among 2,232 participants
enrolled in the Framingham Heart Study. In this study, the
adjusted relationship between AIx/PPA and incident CVE
was not consistent. Although AIx was an independent
predictor of hard CVEs, whereas PPA was an independent
predictor of all CVEs in multivariate analyses, knowledge of
these variables yielded negligible increases in reclassification
and discrimination for these endpoints. Unlike RM, PPA/
AIx were not predictive of incident CHF. We emphasize
that these findings do not indicate that central pulse
pressure is irrelevant for cardiovascular risk, but rather
indicate that, when considering the broad distribution of
brachial pressures within a population, knowledge of the
smaller difference between peripheral and central pulse
pressure (PPA) does not provide substantial incremental
risk prediction for hard CVEs/CHF.
The different predictive performance of AIx compared to
RM has several potential explanations. AIx is not only
influenced by RM but also strongly dependent on reflection
timing, heart rate, body height, and hemodynamic phenom-
ena unrelated to wave reflections (4,9,10,33). Computation
of AIx is dependent on the accuracy of high-frequency
components of measured pressure (which produce sharp
inflections in the waveform), which may be less accurately
reproduced with a generalized transfer function due to their
higher interindividual variability (34). In contrast, RM is
less sensitive to confounding factors listed above and its
computation depends predominantly on low-frequency
pressure harmonics, which relate more consistently between
the aortic and radial sites among different individuals (34)
and may therefore be better reproduced with a generalized
transfer function.
This study is the largest to date to assess the association
between central pressure profiles and incident CVE. Other
strengths of this investigation include the multiethnic
community-based sample, standardized assessments, and
careful event adjudication using hard criteria for CHF/
CVE. However, it is important to acknowledge some
limitations. This observational study cannot prove a causal
link between wave reflections and CHF/CVE. Central flow
was not measured; a physiologic flow waveform was as-
sumed, an imperfect approach that, although better related
to incident CHF/CVE than AIx, provides only an approx-
imation of true RM. This raises the possibility that the
predictive ability of RM may be improved if more accurately
measured with subject-specific flow waveform data. Because
participants had no known cardiovascular disease at base-
line, this cohort represents a particularly healthy sample of
the general population, which is, however, ideal for exam-
ining early vascular changes predisposing to CHF. As a
consequence, the absolute risk of CHF in this cohort wasrelatively low and the observed number of events was
insufficient for gender-specific subanalyses, which, however,
should be feasible in the future as more events accumulate in
the cohort. Despite this large, multiethnic sample, it would
be desirable to replicate the findings in other populations to
better establish their generalizability. Finally, aortic pulse
wave velocity, an index of aortic wall stiffness, which also
impacts LV afterload, was not measured. However, aortic
pulse wave velocity affects predominantly the timing (rather
than the magnitude) of wave reflections, and the LV senses
only operating load and not large arterial material properties
per se. It is possible that aortic pulse wave velocity and RM
provide complementary information about cardiovascular
risk. This should be addressed in future studies.
Conclusions
In an ethnically diverse population free of cardiovascular
disease at baseline, RM was independently associated with
incident CVE and strongly associated with incident CHF.
Arterial wave reflections represent an important novel risk
factor for CHF and a potential therapeutic target for
primary CHF prevention.
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